As a reporter, I have some big questions re:Penn State/myocarditis data:
1.) What was the sample size?
2.) When was the study done and how long after infection were tests completed?
3.) Were follow up studies done on recovery?
4.) Could results be repeated from multiple samples?

If the 30-35% number is accurate, it’s clearly problematic. While myocarditis is usually not life threatening, that risk goes up for athletes. Mayo clinic suggests 3-6 months off from competition if athletes have it.

It’s also worth noting that myocarditis can be caused by LOTS of viruses, so it’s worth asking if the data regarding COVID cases looks worse, better or about the same as other viruses.

Obviously numbers like the Penn State data put a spotlight on the schools still intending to play. Have they found similar results? How are they screening? What’s their treatment strategy? Are players required to sit out if showing any myocarditis symptoms? For how long?

If this data holds up, ACC/SEC/B12 need to seriously rethink plans. But there’s a lot about the study that requires further explanation before you take it at face value. Just like all news stories that start “a new study suggests…” the devils are in the details you don’t hear.

Here’s another thing: The myocarditis risk comes from extensive physical exertion which could lead to heart failure. But that could happen in a practice or workout or lift session. Games really aren’t altering the risk dynamic.